The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility

The physiological roles of the gut microbiota and their metabolites are explored, highlighting their contribution to the onset and progression of metabolic disorders, particularly T2D. We examined the mechanisms through which Metf and FMT influence gut microbiota, insulin sensitivity, and glucose tolerance. Novel therapeutic approaches, including the combined use of Metf and FMT, are discussed in terms of molecular mechanisms, clinical outcomes, and safety profiles. Finally, the potential integration of these strategies into T2D management and their impact on gastrointestinal dysfunction are considered as areas for further research.

Authors

Institutions

Publication Details

Journal
Journal of Advanced Research
Published
2025-09-01
DOI
https://doi.org/10.1016/j.jare.2025.09.021
Citations
3
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
2.42
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility

Jimmy Martín-Delgado, Alessio Porta, Massimiliano Corsi Romanelli, Antonio Ettore Pontiroli et al.
3 citations
Journal of Advanced Research
Gut microbiota and health
2.42
article

The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility

Jimmy Martín-Delgado, Alessio Porta, Massimiliano Corsi Romanelli, Antonio Ettore Pontiroli, Marco D’Anzeo, Elena Dozio, Lorenzo Drago, Cesare Berra, Valentina Carlini, Elena Vianello, Angelo Naselli, Lucia La Sala, Maria Belen Macas-Granizo, Emilio Trabucchi
article en
3 citations

Abstract

The physiological roles of the gut microbiota and their metabolites are explored, highlighting their contribution to the onset and progression of metabolic disorders, particularly T2D. We examined the mechanisms through which Metf and FMT influence gut microbiota, insulin sensitivity, and glucose tolerance. Novel therapeutic approaches, including the combined use of Metf and FMT, are discussed in terms of molecular mechanisms, clinical outcomes, and safety profiles. Finally, the potential integration of these strategies into T2D management and their impact on gastrointestinal dysfunction are considered as areas for further research.

Journal of Advanced Research
Marche Polytechnic University (IT), Universidad Católica de Santiago de Guayaquil (EC), MultiMedica (IT), Ospedale San Paolo (IT), Hospital Luis Vernaza (EC), IRCCS Istituto Auxologico Italiano (IT), Universidad Regional Amazónica IKIAM (EC)
Openalex Percentile: Top 10%
Gut microbiota and health
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The eternal struggle between titans: Fecal microbiota transplant (FMT) versus metformin in type 2 diabetes (T2D) gut dysmotility — Jimmy Martín-Delgado, Alessio Porta, et al. · Journal of Advanced Research (2025) | TGRS Research Map | TGRS